Radiation Oncology/Therapy: Page 66

No need to defer cancer treatment for fear of COVID-19

By Kate Madden Yee

Patients shouldn't postpone their cancer treatment for fear of SARS-CoV-2 infection by visiting healthcare facilities, according to a research letter published online August 27 in JAMA Oncology. Researchers found little risk of infection if appropriate disinfection protocols are followed.

August 26, 2020

Single radiotherapy dose effective for breast cancer

By Theresa Pablos

A single dose of targeted radiotherapy during a lumpectomy procedure proved effective in a long-term clinical trial of thousands of women with early-stage breast cancer. The international team behind the large, randomized trial published their results on August 19 in the BMJ.

August 26, 2020

PET/MRI ups lesion detection by 15% for some cancers

By Rebekah Moan

In a study of more than 1,000 exams, PET/MRI improved lesion detection by more than 15% compared with PET/CT in selected cancers -- namely malignant bone disease and lung cancer. In addition, PET/MRI reduced ionizing radiation by nearly 80% when compared with PET/CT.

August 25, 2020

IBA appoints nonexecutive directors

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) has appointed two nonexecutive directors to its board of directors and audit committee.

August 24, 2020

ART installs breast system in Fla.

By AuntMinnie.com staff writers

Radiation therapy firm Advanced Radiation Therapy (ART) has installed its AccuBoost Digital image-guided partial-breast brachytherapy system at a center in Florida.

August 20, 2020

Case Western lands grant from NCI for AI research

By AuntMinnie.com staff writers

Researchers from Case Western Reserve University in Cleveland have received a $1.15 million grant from the U.S. National Cancer Institute (NCI) to develop artificial intelligence (AI) algorithms for distinguishing between tumors and damaged noncancerous tissue on postoperative MRI exams in cancer patients.

August 17, 2020

Accuray's Q4, fiscal year revenues decline

By AuntMinnie.com staff writers

Radiation oncology firm Accuray has released financial results for its fourth quarter and fiscal year that show a drop in revenue from last year.

August 13, 2020

Report: I-123 shortages force Australia to charter flights

By AuntMinnie.com staff writers

The COVID-19 pandemic has forced Australia to spend hundreds of thousands of dollars on charter flights to import iodine-123 (I-123) radioisotopes for use in cancer treatments, according to an August 10 article in the Guardian.

August 12, 2020

Follow-up SPECT/CT scan tracks radionuclide dose

By Kate Madden Yee

Australian researchers have developed a technique that uses a follow-up SPECT/CT scan after radionuclide therapy to personalize the radiation dose delivered, according to a study published in the July issue of the Journal of Nuclear Medicine.

August 12, 2020

New radiotracer increases multiple myeloma survival

By Rebekah Moan

A new alpha-radioimmunotherapy agent, Pb-212-anti-CD38, prevented tumor growth and increased survival in multiple myeloma tumor-bearing mice, according to new research published in the Journal of Nuclear Medicine.

August 10, 2020

Firm nabs $1.4M for prostate cancer drug

By AuntMinnie.com staff writers

The U.S. National Institutes of Health has awarded biotechnology firm Cancer Targeted Technology $1.4 million in the second year of a grant to fund development of a radiotherapeutic prostate cancer drug.

August 6, 2020

Why Siemens-Varian deal is a win-win for both companies

By Steve Holloway

News of the deal between Siemens Healthineers and Varian Medical Systems will have caught many industry onlookers off guard on Sunday evening. In a new analysis, Stephen Holloway of Signify Research explains why the deal is a great fit for both companies.

August 5, 2020

Previous Page

Page 66 of 465

Next Page